Compare OLMA & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | SPFI |
|---|---|---|
| Founded | 2006 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.3M | 847.8M |
| IPO Year | 2020 | 2019 |
| Metric | OLMA | SPFI |
|---|---|---|
| Price | $10.27 | $43.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $44.89 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 939.2K | 90.6K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | 15.00 | ★ 17.81 |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $22.65 |
| Revenue Next Year | N/A | $9.40 |
| P/E Ratio | ★ N/A | $23.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.36 | $35.34 |
| 52 Week High | $36.26 | $46.94 |
| Indicator | OLMA | SPFI |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 44.10 |
| Support Level | $9.70 | $42.84 |
| Resistance Level | $11.36 | $44.08 |
| Average True Range (ATR) | 0.50 | 0.82 |
| MACD | -0.01 | -0.24 |
| Stochastic Oscillator | 46.99 | 29.11 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.